10-02 :: February 2010
nanotimes
29
Companies
Facts
T
otal revenues for the German Merck Group
(Reuters: MRCG / Bloomberg: MRK GY / Dow
Jones: MRK.DE) reached EUR7,747 million as the
6.5% increase in revenues from the Pharmaceuticals
business sector more than offset the 9.0% decline in
revenues from the Chemicals business sector. During
the fourth quarter, Merck recorded a 5.9% increase
in total revenues to EUR2,029 million.
Research and development costs rose 8.9% to
EUR1,345 million in 2009. Total revenues for the
Liquid Crystals division continued to climb since
the low point in the first quarter of 2009. Although
sales fell by 17% to EUR733 million in 2009.
Merck KGaA and Millipore Corporation (NYSE: MIL)
have entered into a definitive agreement under
which Merck KGaA will acquire all outstanding
shares of common stock of Millipore, for US$ 107
per share in cash, or a total transaction value, inclu-
ding net debt, of approximately EUR5.3 billion (US$
7.2 billion).

http://www.merck.de

http://www.millipore.com
N
ano Mask, Inc. appointed Michael J. Marx to its
board of directors. Mr. Marx was appointed as
the Company‘s Chief Financial Officer on December
21, 2009.

http://www.nanomask.com
N
anometrics Incorporated (NASDAQ: NANO)
announced financial results for its fiscal fourth
quarter and full year ended January 2, 2010: Product
revenues increased 23% over the third quarter of
2009, and total revenues increased 2% quarter-on-
quarter and 29% year-on-year to $26.3 million. In
fiscal year 2009 revenues were $76.7 million, down
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69